Read more…. - MJN e-News

echinoidclapBiotechnology

Dec 1, 2012 (4 years and 6 months ago)

186 views


1



G r o wt h P a r t n e r s h i p

C o mp a n y


Generic Drug Market Picks up Steam in the Southeast Asian
Pharmaceuticals Industry, Finds Frost & Sullivan


SINGAPORE,
22 November, 2010
-

The Southeast Asian pharmaceuticals
industry is in a state of transition and the gener
ic drug market is slowly
gaining more attention from both patients and governments. In order to
achieve growth, companies are reorganizing and reinventing themselves
to diversify their business. New business strategies and product
development paradigms are

being unleashed to cash in on the growth
opportunities. Outsourcing of manufacturing and internal functions is the
current trend.


In most

of the

emerging markets in Southeast Asia, there are changes in
consumption patterns; however, the focus on primary
care persists. In the
developed countries such as Australia, the central nervous system and
oncology segments are expected to thrive.


New analysis from
Frost & Sullivan

(
http://www.pharma.frost
.com
),
Southeast Asian Pharmaceuticals Industry: Generic Drug Market
,
discovers that the Southeast Asua m
arket
earned revenues of over USD
6,803.7million in 2009 is estimated to reach USD
10,827.0
million by
2016. The study covers Malaysia, Philippines, S
ingapore and Thailand.



“The Malaysian drug market is the largest, comprising 47.8 percent of the
total pharmaceutical market,” says

Frost & Sullivan

Industry Analyst
Jennifer Lau.


Lau further notes,
“Strong governmental support, stable economy, and
a
b
ooming population are other factors fuelling
the
market momentum.”


Though the pharmaceuticals industry in The Philippines is large, the
generic drug market is small, accounting for only 19.6 percent. Moreover,
the lackluster macroeconomic environment in t
he country reduces the
attraction quotient for the market.


“In Singapore, the efficient regulatory setup and the stable
macroeconomic environment have enabled a high
er

level of interest
in
generic drugs with
in the country,” says Lau. “On the flip side, th
e small
size of the market and the low population limit the possibilities of market
growth.”


Although the generic drug market in Thailand is large, the weak
macroeconomic environment detracts from its potential. Competition in
the Thai generic drug market

is not intense, as it is dominated by local
participants.



2

Although the market holds opportunities, there are some challenges
restraining the pace of growth. Growing acceptance of generic drugs has
led to pricing pressure. The Thai Government is initiatin
g policies to
restrain rising healthcare cost.


An increase in the availability of herbal products and high levels of
awareness regarding the holistic approach to healthcare are also clouding
market prospects. Companies must roll out strong marketing strat
egies
and offer products with superior quality to ensure productive business
outcomes.


If you are interested in more information on this study, please send an e
-
mail to
Nicklaus Au
, Corporate Communications, at
n
icklaus.au@frost.com
,
with your full name, company name, title, telephone number, company e
-
mail address, company website, city, state and country.


Southeast Asian Pharmaceuticals Industry: Generic Drug Market
is
part of the
Pharmaceutical & Biotechnolog
y

Growth Partnership
Services program, which also includes research in the following markets:
Drug Discovery Outsourcing Market in China, Overview of Diabetes
Therapeutics Market in China and India, and Generic Drug Market Japan,
among others. All research

services included in subscriptions provide
detailed market opportunities and industry trends that have been
evaluated following extensive interviews with market participants.



About Frost & Sullivan


Frost & Sullivan
, the Growth Partnership Company, enab
les clients to
accelerate growth and achieve best
-
in
-
class positions in growth,
innovation and leadership. The company's Growth Partnership Service
provides the CEO and the CEO's Growth Team with disciplined research
and best
-
practice models to drive the g
eneration, evaluation, and
implementation of powerful growth strategies.
Frost & Sullivan

leverages
over 45 years of experience in partnering with Global 1000 companies,
emerging businesses and the investment community from 40 offices on
six continents. To

join our Growth Partnership, please visit
http://www.frost.com
.




MEDIA CONTACT:


Donna Jeremiah

Corporate Communications


Asia Pacific

P: +603 6204 5832

F: +603 6201 7402

E:
d
jeremiah@frost.com


Nicklaus Au

Corporate Communications


Asia Pacific

P: +603 6204 5836


3

F: +603 6201 7402

E:
nicklaus.au@frost.com